Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has been given an average rating of "Hold" by the thirteen analysts that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $34.90.
A number of brokerages have recently commented on OSCR. Wells Fargo & Company increased their target price on shares of Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research report on Thursday, August 13th. Piper Sandler reissued an "overweight" rating and issued a $48.00 price target on shares of Oscar Health in a research note on Thursday, September 17th. Zacks Research upgraded shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 6th. UBS Group upped their price objective on shares of Oscar Health from $26.00 to $36.00 and gave the company a "neutral" rating in a research note on Monday, October 12th. Finally, Raymond James Financial upped their price objective on shares of Oscar Health from $34.00 to $42.00 and gave the company an "outperform" rating in a research note on Friday, September 18th.
Get Our Latest Stock Report on Oscar Health
Insider Buying and Selling at Oscar Health
In related news, Director Vanessa Wittman sold 25,000 shares of the stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $32.24, for a total value of $806,000.00. Following the completion of the sale, the director owned 112,121 shares of the company's stock, valued at approximately $3,614,781.04. This trade represents a 18.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Liang sold 10,360 shares of the stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $325,822.00. Following the completion of the sale, the insider directly owned 248,697 shares of the company's stock, valued at approximately $7,821,520.65. This represents a 4.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 874,451 shares of company stock worth $26,761,671. 22.64% of the stock is owned by company insiders.
Institutional Trading of Oscar Health
Several large investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP raised its holdings in shares of Oscar Health by 22.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company's stock worth $48,078,000 after acquiring an additional 759,837 shares during the period. Bank of America Corp DE boosted its position in shares of Oscar Health by 205.1% during the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company's stock valued at $32,808,000 after acquiring an additional 1,922,732 shares during the last quarter. Assenagon Asset Management S.A. boosted its position in shares of Oscar Health by 107.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company's stock valued at $79,867,000 after acquiring an additional 1,341,716 shares during the last quarter. Halter Ferguson Financial Inc. boosted its position in shares of Oscar Health by 93.3% during the 3rd quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company's stock valued at $37,373,000 after acquiring an additional 584,818 shares during the last quarter. Finally, Wedge Capital Management L L P NC purchased a new stake in shares of Oscar Health in the second quarter valued at about $32,855,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Oscar Health Price Performance
NYSE:OSCR opened at $30.99 on Friday. The firm has a market cap of $9.56 billion, a P/E ratio of 22.14, a price-to-earnings-growth ratio of 0.37 and a beta of 2.47. The stock has a 50 day moving average of $31.78 and a two-hundred day moving average of $27.35. Oscar Health has a 12 month low of $10.69 and a 12 month high of $35.01. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. During the same period in the previous year, the company posted ($0.89) earnings per share. The business's revenue was up 70.4% on a year-over-year basis. On average, analysts expect that Oscar Health will post 1.83 earnings per share for the current fiscal year.
About Oscar Health
(
Get Free Report)
Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act's health insurance marketplace, as well as small businesses and their employees.
Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.